Delivra Health Brands Inc

Company Profile

Delivra Health Brands Inc had its IPO on under the ticker symbol DHBUF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Delivra Health Brands Inc has a staff strength of 0 employees.

Stock update

Shares of Delivra Health Brands Inc opened at $0.02 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.02 - $0.02, and closed at $0.02.

This is a -10.53% slip from the previous day's closing price.

A total volume of 150 shares were traded at the close of the day’s session.

In the last one week, shares of Delivra Health Brands Inc have increased by +54.55%.

Delivra Health Brands Inc's Key Ratios

Delivra Health Brands Inc has a market cap of $3.86 million, indicating a price to book ratio of 1.6636 and a price to sales ratio of 0.4818.

In the last 12-months Delivra Health Brands Inc’s revenue was $8.40 million with a gross profit of $2.60 million and an EBITDA of $-1703000. The EBITDA ratio measures Delivra Health Brands Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Delivra Health Brands Inc’s operating margin was -37.6% while its return on assets stood at -16.78% with a return of equity of -54.92%.

In Q1, Delivra Health Brands Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0.6%.

Delivra Health Brands Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.01 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Delivra Health Brands Inc’s profitability.

Delivra Health Brands Inc stock is trading at a EV to sales ratio of 0.5361 and a EV to EBITDA ratio of -1.1663. Its price to sales ratio in the trailing 12-months stood at 0.4818.

Delivra Health Brands Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$10.31 million

Total Liabilities

$5.45 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Delivra Health Brands Inc ended 2024 with $10.31 million in total assets and $0 in total liabilities. Its intangible assets were valued at $10.31 million while shareholder equity stood at $3.37 million.

Delivra Health Brands Inc ended 2024 with $0 in deferred long-term liabilities, $5.45 million in other current liabilities, in common stock, $-170032000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $2.92 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $1.50 million.

Delivra Health Brands Inc’s total current assets stands at $7.33 million while long-term investments were $0 and short-term investments were $13000.00. Its net receivables were $1.24 million compared to accounts payable of $2.19 million and inventory worth $2.63 million.

In 2024, Delivra Health Brands Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Delivra Health Brands Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.02

52-Week High

$0.0268

52-Week Low

$0.0096

Analyst Target Price

$

Delivra Health Brands Inc stock is currently trading at $0.02 per share. It touched a 52-week high of $0.0268 and a 52-week low of $0.0268. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.01 and 200-day moving average was $0.01 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 2213.1% of the company’s stock are held by insiders while 0% are held by institutions.